文献速递主动脉疾病

降主动脉瘤治疗进展与长期生存:单中心1984-2014年经验

Advances in Treatment and Long-term Survival in Patients with Descending Thoracic Aortic Aneurysms Treated at a Single Tertiary Center from 1984 to 2014.
PubMed 文献 · Ann Vasc Surg · 2019-02-04

该研究回顾性分析了1984至2014年间单中心202例接受开放手术或TEVAR治疗的降主动脉瘤患者,旨在评估向TEVAR转变对长期生存的影响。结果显示开放手术 operative mortality 高于TEVAR,但术后30天以后长期生存无差异;

要点

  • 开放手术 operative mortality 高于TEVAR,但术后30天以后长期生存无差异。
  • 脊髓损伤发生率0.5%,卒中发生率1%,低脊髓损伤率与较长生存相关。

核心结论

  • 开放手术 operative mortality 高于TEVAR,但术后30天以后长期生存无差异。

研究设计与样本

  • 使用前瞻性维护的登记数据库,纳入1984至2014年间单中心202例接受开放手术或TEVAR治疗的降主动脉瘤患者。
  • 通过医院记录、社会保障死亡数据库和在线记录核实所有患者的最后接触日期或死亡日期。
  • 计算生存曲线,并按年龄、术前变量、手术方式和医院并发症进行比较;采用比例风险模型进行生存多因素分析。

主要发现

  • 28%的患者有夹层,41.6%急性起病,68.8%接受TEVAR,31.1%接受开放手术。
  • 脊髓损伤发生率为0.5%,卒中发生率为1%。
  • operative mortality 为5.9%,与急性程度、呼吸衰竭、开放手术方式和年龄相关。
  • 全组1年生存率为83.7%;1年死亡与急性程度、开放手术、呼吸衰竭、医院并发症和冠状动脉旁路移植术(CABG)相关。

关键数值与推荐

  • 开放手术患者1年生存率为76%,TEVAR患者为87%。
  • 排除 operative mortality 后,1年生存率为89%,5年生存率为64.2%,TEVAR与开放手术的长期生存无差异。
  • 排除 operative mortality 后,1年死亡与CABG和医院并发症相关;5年生存无相关变量。

临床怎么用

  • 对于降主动脉瘤患者,TEVAR可降低 operative mortality,但术后30天以后长期生存与开放手术相当。
  • 术后1年死亡风险与急性程度、开放手术、呼吸衰竭、医院并发症和CABG相关,应加强围术期管理。
  • 低脊髓损伤率(0.5%)与较长生存相关,提示应重视脊髓保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We report long-term survival in open surgical and endovascular patients treated for descending thoracic aortic aneurysms (TAAs) at a single tertiary center from 1984 to 2014 to study the impact of transition to thoracic endovascular aortic repair (TEVAR) for TAA repair. METHODS: Using a prospectively maintained registry, all patients (n = 202) having open or endovascular repair (TEVAR) of descending TAAs were studied. Date of last contact or death was obtained on all patients from hospital records, Social Security Death Database, and verified online records. Survival curves were computed and compared by age, preoperative variables, surgical approach, and hospital complications. Proportional hazards models were used for multivariate analysis of survival. RESULTS: In total, 28% had dissection, 41.6% presented acutely, 68.8% had TEVAR, and 31.1% had open surgery. Spinal cord injury (SCI) occurred in 0.5% and stroke in 1%. Operative mortality (5.9%) was associated with acuity, respiratory failure, open approach, and age. One-year survival in all patients was 83.7%. One-year mortality was associated with acuity, open surgery, respiratory failure, hospital complications, and coronary artery bypass surgery (CABG). Five-year survival was 60.4% and not associated with other variables. One-year survival was 76% in open patients and 87% in TEVAR patients. When operative mortality was excluded, 1-year survival was 89% and 5-year survival was 64.2% and there was no difference in long-term survival between TEVAR and open surgery. One-year mortality was associated with CABG and hospital complications. No variables were associated with 5-year survival. Ten-year survival was 35% and predicted only by age at operation. CONCLUSIONS: Operative mortality was higher in open surgery than TEVAR, but after 30 days, long-term survival was the same. Eighty-nine percent of patients were alive 1 year after surgery and 64% were alive 5 years after surgery. Low SCI contributed to longer survival.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Acher C, Acher CW, Havlena J, et al. Advances in Treatment and Long-term Survival in Patients with Descending Thoracic Aortic Aneurysms Treated at a Single Tertiary Center from 1984 to 2014. Ann Vasc Surg. 2019. PMID: 30731225. doi:10.1016/j.avsg.2018.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。